Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) will release its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. A conference call to discuss the results begins at 8:30 a.m. Eastern Time and will be accessible by phone or webcast.
Replays will be available by phone and online from approximately 10:30 a.m. Eastern Time on July 23, 2026, until midnight Eastern Time on August 6, 2026. Listeners are encouraged to review the company’s SEC filings, including risk factors and historical results.
Positive
- None.
Negative
- None.
News Market Reaction – DGX
In the Jun 17 session, DGX declined 1.63%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 19 | Earnings date announcement | Neutral | -0.6% | Set timing and access details for Q1 2026 earnings release and call. |
| Jan 8 | Earnings date announcement | Neutral | -0.2% | Announced Q4 2025 and FY 2025 earnings release date and call logistics. |
| Dec 9 | Earnings date announcement | Neutral | -1.2% | Communicated timing for a financial and operating results release and call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date announcements for DGX have been followed by modestly negative one-day moves, suggesting a pattern of mild drift around these scheduling updates.
Recent news shows DGX steadily communicating around financial milestones. Prior earnings-date notices on Jan 8, 2026 and Mar 19, 2026 outlined upcoming quarterly results and access details, with small negative price reactions. Alongside this, DGX reported strong Q1 2026 results and raised full-year guidance, and maintained capital actions like dividends and senior notes offerings. Today’s Q2 2026 earnings-date announcement continues this regular disclosure cadence.
Key Terms
securities and exchange commission regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The conference call can be accessed by dialing 888-455-0391 within the
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on July 23, 2026, until midnight Eastern Time on August 6, 2026.
Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors, and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-second-quarter-financial-results-on-july-23-2026-302802200.html
SOURCE Quest Diagnostics